The Food and Drug Administration (FDA) has granted Priority Review to the Biologics License Application (BLA) for deramiocel (CAP-1002) for the treatment ...

The Food and Drug Administration (FDA) has approved Stoboclo® (denosumab-bmwo), a biosimilar to Prolia® (denosumab), and Osenvelt® (denosumab-bmwo), a ...

The Food and Drug Administration (FDA) has approved Purified Cortrophin ® Gel (repository corticotropin injection USP) in a prefilled syringe presentation. Cortrophin Gel is a purified ...

In honor of Women’s History Month, MPR has created a quiz to celebrate the groundbreaking contributions of women in medicine. Test your knowledge and see ...

After adjustment for confounding variables, no increased risk seen for GLP-1 receptor agonists versus DPP-4 inhibitors, SGLT-2 inhibitors ...

Significant reduction seen in median headache days per month in both intractable and nonintractable migraine groups ...

Based on preliminary data for 2024 to 2025, 13% of pediatric deaths had influenza-associated encephalopathy, encephalitis.

Newly appointed health secretary believes processing the comments under the Richardson Waiver puts too heavy a burden on the department ...

The approval was supported by data from the registry-linked, parallel group, open-label, randomized AcT trial, which compared tenecteplase to alteplase.

The Food and Drug Administration (FDA) has granted Fast Track designation to LTG-001 for the treatment of acute pain. LTG-001, an oral Nav1.8 selective ...

Omalizumab was found to be more effective than multi-allergen oral immunotherapy (OIT) in reducing allergic reactions in patients with 1 or more food allergies, according to results from Stage 2 of ...

Hybrid closed-loop insulin delivery does not affect rate of severe hypoglycemia and increases rate of ketoacidosis ...